Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

The research identified key molecules that help hair matrix and dermal papilla cells communicate and influence hair growth in cashmere goats.

Ginseng, especially its component ginsenosides, can promote hair growth, reduce hair loss, and potentially treat conditions like alopecia by affecting cell pathways and cytokines.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Vitamin A is important for healthy skin and hair, influencing hair growth and skin healing, but UV light reduces its levels.

Rosemary may help treat various skin conditions due to its antioxidant and anti-inflammatory properties.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

JAK inhibitors show promise for treating various skin diseases.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

New treatments like nanotechnology show promise in improving skin cancer therapy.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Blocking certain immune signals can reduce skin damage from radiation therapy.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.